According to an order issued on February 18, all Lipitor diabetes lawsuits filed in federal courts throughout the country will be centralized for pretrial proceedings as part of a multidistrict litigation (MDL). U.S. District Judge Richard M. Gergel will oversee the Lipitor complaints, all of which involve similar allegations that Pfizer failed to provide consumers and the medical community with adequate warnings about the risk of diabetes side effects linked to its Lipitor cholesterol medication, especially among women. If you believe you have been adversely affected by side effects of Lipitor, contact a reputable product liability attorney who has experience handling Lipitor diabetes claims. With a qualified lawyer on your side, you may be able to pursue financial compensation for your injuries and medical expenses.
Several hundred product liability lawsuits have already been brought against Pfizer on behalf of women across the country, and a panel of judges ruled that the rapidly increasing number of complaints calls for centralized management to avoid conflicting ruling from different judges, to reduce duplicative discovery, and to serve the convenience of the courts, parties and witnesses involved. In July 2013, the U.S. Judicial Panel on Multidistrict Litigation (JPML) denied a similar request to centralize all Lipitor cases, finding that the few dozen complaints filed at that time were insufficient to justify establishing consolidated proceedings. However, in October 2013, a renewed request was filed to consolidate the Lipitor diabetes lawsuits as part of an MDL, in response to a dramatic increase in the number of complaints pending against Pfizer.
Lipitor (atorvastatin) is a blockbuster cholesterol drug manufactured by Pfizer and approved by the U.S. Food and Drug Administration (FDA) as a means of lowering cholesterol levels and thereby reducing a patient’s risk of cardiovascular disease. However, mounting research has identified Lipitor use in women as a potential risk factor for Type 2 diabetes, which is tied to long-term complications like kidney failure, muscle damage, memory loss and even blindness. In 2012, the FDA updated the Lipitor warning label to include important information about the risk of Type 2 diabetes in women, after researchers found a 50% increased risk of diabetes side effects among women taking prescription statin medications like Lipitor.
High cholesterol is a major health concern among Americans, and, as a result, Lipitor and similar statin drugs are some of the most widely-used medications in the United States. Due to this widespread use, it is expected that several thousand Lipitor diabetes lawsuits will ultimately be filed in the federal court system, as product liability lawyers continue to review claims brought on behalf of women diagnosed with the disease. If you took Lipitor to lower your cholesterol, and you have since suffered from complications of Type 2 diabetes or another serious side effect, our consumer advocates at the Consumer Justice Foundation can help. We are dedicated to protecting the rights of consumers harmed by dangerous pharmaceutical drugs, and can help put you in touch with an experienced Lipitor attorney today.